Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
Open Access
- 29 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 7 (1), 16
- https://doi.org/10.1186/1476-4598-7-16
Abstract
Background: We have recently shown that curcumin (a diferuloylmethane, the yellow pigment in turmeric) enhances apoptosis-inducing potential of TRAIL in prostate cancer PC-3 cells, and sensitizes TRAIL-resistant LNCaP cellsin vitrothrough multiple mechanisms. The objectives of this study were to investigate the molecular mechanisms by which curcumin sensitized TRAIL-resistant LNCaP xenograftsin vivo.Methods: Prostate cancer TRAIL-resistant LNCaP cells were implanted in Balb c nude mice to examine the effects of curcumin and/or TRAIL on tumor growth and genes related to apoptosis, metastasis and angiogenesis.Results: Curcumin inhibited growth of LNCaP xenografts in nude mice by inducing apoptosis (TUNEL staining) and inhibiting proliferation (PCNA and Ki67 staining), and sensitized these tumors to undergo apoptosis by TRAIL. In xenogrfated tumors, curcumin upregulated the expression of TRAIL-R1/DR4, TRAIL-R2/DR5, Bax, Bak, p21/WAF1, and p27/KIP1, and inhibited the activation of NFκB and its gene products such as cyclin D1, VEGF, uPA, MMP-2, MMP-9, Bcl-2 and Bcl-XL. The regulation of death receptors and members of Bcl-2 family, and inactivation of NFκB may sensitize TRAIL-resistant LNCaP xenografts. Curcumin also inhibited number of blood vessels in tumors, and circulating endothelial growth factor receptor 2-positive endothelial cells in mice.Conclusion: The ability of curcumin to inhibit tumor growth, metastasis and angiogenesis, and enhance the therapeutic potential of TRAIL suggests that curcumin alone or in combination with TRAIL can be used for prostate cancer prevention and/or therapy.Keywords
This publication has 70 references indexed in Scilit:
- Linkage of Curcumin-Induced Cell Cycle Arrest and Apoptosis by Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1Cell Cycle, 2007
- Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma IntravasationJournal of Biological Chemistry, 2006
- Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and modulation of apoptosisMolecular Carcinogenesis, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: Involvement of both death receptor and mitochondrial pathwaysInternational Journal of Molecular Medicine, 2005
- Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.2005
- Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.2003
- NF-κB in cancer: a marked targetSeminars in Cancer Biology, 2003
- Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding siteOncogene, 2000
- The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to NucleusScience's STKE, 1999